Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome

NCT01951001 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

255

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome
Platelet Thrombus
Bleeding

Interventions

DRUG: Prasugrel

Sponsor

Gyeongsang National University Hospital